1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Global Mass Spectrometry Analysis, By Mass Analyzer/Ion Separation
5.1. Introduction
5.2. Quadrupole Mass Analyzer
5.3. Time of flight Mass Analyzer
5.4. Magnetic Sector Mass Analyzer
5.5. Electrostatic Mass Analyzer
5.6. Quadrupole Ion Trap Mass Analyzer
5.7. Ion Cyclotron Resonance
6. Global Mass Spectrometry Analysis, By Industry
6.1. Pharmaceutical
6.2. Biotechnology
6.3. Space Research
6.4. Food Testing
7. Global Mass Spectrometry Analysis, By Geography
7.1. Introduction
7.2. North America
7.2.1. USA
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. Germany
7.4.2. France
7.4.3. UK
7.4.4. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. UAE
7.5.3. Others
7.6. Asia Pacific
7.6.1. China
7.6.2. India
7.6.3. Japan
7.6.4. South Korea
7.6.5. Taiwan
7.6.6. Thailand
7.6.7. Indonesia
7.6.8. Others
8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. Company Profiles
9.1. 908 Devices
9.2. AB SCIEX
9.3. Advion
9.4. Agena Biosciences
9.5. Bioflyte
9.6. Biognosys
9.7. Chiesi
9.8. GlaxoSmithKline
9.9. Intervenn Biosciences
9.10. Sphere Fluidics
List of Figures
List of Tables